Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, September 17, 2024
Serán Bioscience announced a strategic growth transaction of more than $200 million. Bain Capital Life Sciences led the transaction, while existing investor Vivo Capital remains a key shareholder in the company.
read more
Serán Bioscience’s announced that their state-of-the-art, large-scale spray dryer is now fully operational and is being used to support late-stage clinical drug product portfolios. The SD-720 spray drying system was custom designed and built by Serán...
read more
SeraCare Life Sciences, a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, today announced that Charlie Mamrak joined the company as CEO ...
read more
Thursday, January 31, 2019
seqWell and Gencove announced a partnership for seqWell's plexWell library preparation and Gencove's imputation and analysis software to provide a solution for low-pass whole genome sequencing.
read more
Thursday, October 07, 2021
Seqirus, a global leader in influenza prevention and a business of CSL Limited (ASX:CSL), today announced that the Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness ...
read more
Seqens will open a 366,000-square-foot lab today that is close to Paris and will serve as the company’s center of excellence in its Porcheville facility.
read more
Tuesday, February 18, 2025
France-based SEQENS announced that Pascal Villemagne has been named Chief Executive Officer, effective 1st April 2025.
read more
SEQENS announced a multi-million-dollar investment in its research and development laboratory located in Devens, Mass. The improvements will ensure that the new facility will operate at the highest standards of safety and quality, while also ...
read more
Tuesday, January 31, 2023
Seqens Group, an integrated company involved in the development and manufacture of active pharmaceutical ingredients (APIs) and intermediates, has opened Seqens Boston R&D Center, a state-of-the-art, 15,000 square-foot R&D center in Devens, Mass. ...
read more
Tuesday, September 22, 2020
Seqens CDMO North America has appointed Jean-Noel David as Managing Director for North America.
read more
Wednesday, September 22, 2021
Seqens CDMO, a pharmaceutical manufacturer of new chemical entities (NCEs), active pharmaceutical ingredients (APIs) and other specialty chemical products, announced that Bob Huang has joined as Managing Director for North America. The company is a ...
read more
Sepha, a Northern Ireland-based manufacturer of pharmaceutical packaging and equipment, has developed a new compact small-batch blister packaging machine with full traceability and electronic data storage capabilities. The EZ Blister+ meets increased...
read more
Friday, February 05, 2021
Sepha has launched a contract packaging service for small batch production.
read more
Sentinel Capital Partners announced the sale of WellSpring Pharma Services, a North American pharmaceutical contract manufacturing organization. Terms of the deal were not disclosed.
read more
Tuesday, November 08, 2011
Sentinel Capital Partners, a private equity firm that invests in promising lower middle market companies, today announced its acquisition of WellSpring Pharmaceutical Corporation, a North American manufacturer and marketer of specialty prescription ...
read more